On this page
Read the experiment
The finding and its boundary
The investigators reported attenuation of injury-associated leak-point-pressure reductions; healthy-rat pressure was not changed. An animal pressure endpoint does not establish symptom relief or a treatment choice for people.
Salutary effect of gastric pentadecapeptide BPC 157 in two different stress urinary incontinence models in female rats.
- Experiment
- Experimental animal investigation with the intervention and outcomes specified in the indexed abstract.
- Study system
- Female rats after urethrolysis or prolonged vaginal dilation
- Measured outcome
- Leak-point pressure and vesicourethral tissue measures
- Reported result
- The investigators reported attenuation of injury-associated leak-point-pressure reductions; healthy-rat pressure was not changed.
- What this cannot establish
- An animal pressure endpoint does not establish symptom relief or a treatment choice for people.
What was actually tested
Female rats after urethrolysis or prolonged vaginal dilation. The investigators measured leak-point pressure and vesicourethral tissue measures. The investigators reported attenuation of injury-associated leak-point-pressure reductions; healthy-rat pressure was not changed.
The detail that changes the takeaway
The unchanged result in healthy rats is informative and should not disappear from a healing summary. The two injury procedures model particular stresses, not every cause of incontinence. Patient-reported leakage, quality of life and durability would need to be tested directly in clinical research.
How far the result travels
An animal pressure endpoint does not establish symptom relief or a treatment choice for people.
A useful comparison
The closest related reading is the BPC-157 and an established fistula in rats: delayed treatment is still preclinical appraisal. A surgically created fistula and urinary continence are different endpoints: closing an abnormal passage does not demonstrate restoration of pressure control or relief of symptoms.
The service question
The CareFirst capsule service review addresses prescription filling and the form supplied. Neither its catalog nor this pressure experiment establishes that a capsule has been tested for human urinary symptoms.
References & product documents
The evidence and service information used here.